Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elles M Screever

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Molecular Sciences|March 11, 2023
Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic PerformanceCarolin Pozder, Elles M Screever, A Rogier van der Velde, et al.
JACC. Cardiooncology|August 24, 2023
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart FailurePieter F van den Berg, Joseph Pierre Aboumsallem, Elles M Screever, et al.
European Journal of Heart Failure|October 12, 2022
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkersCanxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, et al.
NPJ Cardiovascular Health|September 22, 2025
The immune checkpoint TIM-3/HMGB-1 axis in myocardial infarctionLaura I Yousif, Aukje G Sijtema, Ymke Appels, et al.
Nature|November 17, 2022
T cells specific for α-myosin drive immunotherapy-related myocarditisMargaret L Axelrod, Wouter C Meijers, Elles M Screever, et al.
Cancer Discovery|December 1, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic InterventionSpencer C Wei, Wouter C Meijers, Margaret L Axelrod, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Molecular Sciences|March 11, 2023
Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic PerformanceCarolin Pozder, Elles M Screever, A Rogier van der Velde, et al.
JACC. Cardiooncology|August 24, 2023
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart FailurePieter F van den Berg, Joseph Pierre Aboumsallem, Elles M Screever, et al.
European Journal of Heart Failure|October 12, 2022
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkersCanxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, et al.
NPJ Cardiovascular Health|September 22, 2025
The immune checkpoint TIM-3/HMGB-1 axis in myocardial infarctionLaura I Yousif, Aukje G Sijtema, Ymke Appels, et al.
Nature|November 17, 2022
T cells specific for α-myosin drive immunotherapy-related myocarditisMargaret L Axelrod, Wouter C Meijers, Elles M Screever, et al.
Cancer Discovery|December 1, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic InterventionSpencer C Wei, Wouter C Meijers, Margaret L Axelrod, et al.
Pageof 2